Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer
In Brief: Hammond Resigned As ACS Officer; Wykoff Slated To Direct FDA Special Populations Office
Cancer society, In Major Restructure, Forms New Executive Committee, Bylaws
Mass. Passes Tobacco Tax, ACS Lauds Victory Over Cigarette Industry
DCE To Provide $3.4 Mil. For Follow-Up Of DES Daughters; Board k’s Tw RFAs, Contracts
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- No need for a speculum? A new era of HPV screening
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- At AACR, Letai announces prevention and screening project for southern Appalachia, describes a future without paylines
There’s “clear evidence that funding is moving and the system is working.” - Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Forty years after Chernobyl: Little evidence to show that radiation released from the accident increased cancers globally









